FREDERIK VAN HOECKE
Show
Sort by
-
Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium
-
Hepatitis E virus serology and PCR : does the methodology matter?
-
Hepatitis E virus serology and PCR : does the methodology matter?
-
Clinical burden of hepatitis E infections in Belgium
-
Hepatitis E seroprevalence in Belgium
-
Serological assessment of HEV in unexplained acute hepatitis
-
Hepatitis E seroprevalence in East and West Flanders, Belgium
-
Evaluation of two new automated chemiluminescent assays (HemosIL® AcuStar HIT-IgG and HemosIL® AcuStar HIT-Ab) for the detection of heparin-induced antibodies in the diagnosis of heparin-induced thrombocytopenia
-
Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
-
Hepatitis E seroprevalence in Belgium
-
Performance evaluation of a modified chromogenic medium, ChromID MRSA New, for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens
-
Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays